Act on discounts for medicines

Unofficial table of contents

AMRabG

Date of completion: 22.12.2010

Full quote:

" Law on discounts for medicines of 22 December 2010 (BGBl. I p. 2262, 2275), as defined by Article 3a of the Law of 7 August 2013 (BGBl. 3108).

Status:

Amended by Art. 3a G v. 7.8.2013 I 3108

For more details, please refer to the menu under Notes

Footnote

(+ + + Text evidence from: 1.1.2011 + + +) 

  

The G was decided by the Bundestag as Article 11a of the G v. 22.12.2010 I 2262. It's gem. Article 12 (1) of this Act entered into force on 1 January 2011. Unofficial table of contents

§ 1 Claim for Abstops

The pharmaceutical companies shall have private health insurance companies and costs incurred in sickness, care and birth cases in accordance with civil service legislation for medicinal products subject to medical prescription, the costs of which shall be have, in whole or in part, been reimbursed, in accordance with the share of the cost contribution, to grant social codes in accordance with Section 130a (1), (1a), (2), (3), (3a) and (3b) of the Fifth Book of Social Code. This also applies to other carriers of costs in cases of illness, which bear these in the context of a protection in the event of illness, by means of which an insurance obligation pursuant to § 193 (3) sentence 1 of the Insurance Contract Law and in accordance with § 5 (1) Number 13 of the Fifth Book of the Social Code is excluded. For the purpose of determining the deductises as set out in the first sentence, any self-or self-content which companies have agreed to with the policyholders or which are based on civil servants ' legal provisions or other provisions shall not be taken into account. shall be considered. The deductions provided for in the first sentence may be used by the private health insurance companies exclusively to avoid or limit premium increases or to reduce the premium on the insurance holdings. Unofficial table of contents

§ 2 Proof

The private health insurance companies and the providers of costs in sickness, nursing and birth cases according to official legal regulations form a central body in the association of private health insurance, which is responsible for the entry of the Charges will be charged. For the purpose of proof of the abatement, the central office or a body responsible for the assessment shall send the pharmaceutical central number of the medicinal product concerned, the date of delivery, the pharmacy identification mark and the proportion of the cost of the product to the pharmaceutical entrepreneurs. The pharmaceutical companies shall reimburse the charges within ten days after the claim has been made. The costs of sickness, care and birth costs in accordance with the rules of civil service law and the association of private health insurance may be borne by the leading organisations of the leading organisations of the For pharmaceutical companies, further details of the settlement and the payment period may also be agreed by way of derogation from this law. Other carriers according to § 1 sentence 2 shall be entitled to carry out the settlement of the charges either themselves or to have them carried out by the central body with appropriate participation at the costs. They may accede to the agreements referred to in the fourth sentence. Unofficial table of contents

§ 3 Examination by trustees

In justified cases, as well as in samples, the pharmaceutical companies can have a trustee to check the accounting of the charges. For this purpose, the personal data required for the purpose of the examination may be transmitted to the trustee. Reproductions of digitised regulation sheets may also be submitted for proof. The trustee shall process and use the data transmitted to him only for the purpose of checking the billing of the charges. Further details of the examination may be provided in the agreement according to § 2 sentence 4. Unofficial table of contents

§ 4 Information on the regulation sheet

In the case of the supply of medicinal products subject to the obligation to surrender pursuant to Article 130a (1), (1a), (2), (3), (3a) or (3b) of the Fifth Book of the Social Code, to persons who do not receive them by way of benefits in kind under the statutory health insurance scheme, In addition to the dispensing price, pharmacies have the pharmaceutical central number, the date of delivery and the pharmacy mark to be transferred to the same in machine-readable form if the prescription sheet is suitable. Further details may be provided by the institution of the costs in the case of sickness, care and birth cases in accordance with the provisions of civil service law and by the Association of Private Health Insurance, with the aid of the Top organization of pharmacists also deviate from this law. In particular, it may be agreed that pharmacies shall issue a receipt in machine-readable form via the pharmaceutical central number of the medicinal product dispensed, the purchase price and the delivery date. Other institutions according to § 1 sentence 2 may accede to the agreement in accordance with sentence 2. Unofficial table of contents

§ 5 Data transfer by pharmaceutical companies

The pharmaceutical companies are obliged to provide the necessary price and product information for medicinal products, including the cover of the association of private health insurance, and on request to the carriers of the costs in sickness, care and care. , and to transmit to other institutions according to § 1 sentence 2 or to one or more of these notified bodies on machine-readable data carriers.